IonQ Inc: Revenue Momentum Continues, 256-Qubit Roadmap on Track

Core Conclusion

IonQ has delivered four consecutive quarters of 20–50% revenue beats above guidance, including a 31% beat in Q1 2026. The company raised its full-year 2026 revenue guide from $235mn to $265mn, and the implied second-half run rate of ~$66mn per quarter sits below the top end of Q2 guidance ($68mn), suggesting further upward revisions are likely. Technology milestones remain on schedule: the 256-qubit system is in late-stage testing, with customer demonstrations expected by year-end and first deliveries in H1 2027. However, these positive trends do not resolve the fundamental question of whether IonQ’s trapped-ion architecture will achieve a broad commercial advantage. At $52.57, the stock trades above our $48.50 target (based on 45x FY27 P/S), leaving limited upside. We maintain an Equal-weight rating.

Evidence Chain

Revenue growth is accelerating, driven by a broadening customer base. Q1 2026 revenue of $64.7mn grew 755% year-over-year, though acquisitions (Skyloom, Seed Innovations, ~$200mn stock combined, closed late January) contribute part of that. The company disclosed for the first time that one-third of revenue comes from customers who have purchased more than one product, indicating cross-selling traction.

Guidance appears conservative, implying future beats. The $265mn 2026 revenue guide – up from $235mn – implies average Q3/Q4 revenue of $66mn, versus the Q2 guidance upper end of $68mn. Acquired businesses generated $51mn in 2025 and were likely at an $80mn run-rate exiting 2025. IonQ’s organic growth guide of >100% on a $79mn base suggests the remainder of the portfolio grows very little versus that exit rate, making beats probable.

256-qubit system is on track. The system is progressing through final testing; two announced customers (University of Cambridge, Horizon Quantum) have existing relationships with IonQ (Cambridge via Oxford Ionics; IonQ owns 13% of Horizon). While neither sale is game-changing, the milestone validates roadmap execution.

Key Disagreements and Risks

Technology scalability remains unproven. The company’s own architecture paper states: “scaling to the regime of thousands of physical qubits is a significant challenge.” Management’s confidence that EQC scaling is not a “heavy technical lift” contrasts with this published caution. DARPA’s heterogeneous architecture contract, which IonQ cited, underscores that the optimal architecture is not settled.

Commercial advantage is not established. IonQ stands out among quantum hardware peers, but “broad commercial advantage remains an open question.” Revenue generation at this stage is secondary to the binary bet on who achieves fault-tolerant quantum advantage first. The market already prices a high probability of success.

Acquisition contribution is opaque. The 10-Q will clarify how much of the beat came from Skyloom and Seed Innovations. If organic growth is materially lower than headline figures, the premium multiple becomes harder to justify.

Valuation and Trading Implications

Our $48.50 target price is derived from 45x FY27 P/S, the midpoint of our 35–55x base-case range, which is a 1.5-standard-deviation discount to the trailing 12-month average P/S multiple. This discount reflects the long-duration nature of the opportunity and the dilutive impact of recent non-quantum M&A.

Current price ($52.57) implies a ~54x FY27 P/S, above our target. The stock already reflects a large portion of the bull-case outcome. IonQ’s $19.5bn market cap implies a strategic value consistent with leadership in a $65bn+ TAM (2030), but offers no margin of safety until the market inflects.

Downside risk: If quantum advantage is delayed or another architecture wins, the stock could fall to net cash (~$6 per share by end-2027). Our bear case values the company at cash only, reflecting the binary nature of the thesis.

Appendix: Revenue and Adjusted EBITDA Summary